Sanofi-Aventis SA, France’s biggest drugmaker, plans further expense reductions in areas such as marketing to offset lower revenue that’s resulting from health- care reforms in Europe.
“The way to cope with that is to continue to cut costs,” Chief Financial Officer Jerome Contamine said at a conference yesterday in Los Angeles organized by Goldman, Sachs & Co. “We are restructuring. We are changing our marketing model. We are merging sales forces, we are reducing sales forces, having a multiproduct sales force. We will continue to do that.”
No comments:
Post a Comment